[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
September 24, 2008

Exenatide Risk

JAMA. 2008;300(12):1403. doi:10.1001/jama.300.12.1403-c

The Food and Drug Administration (FDA) has received several reports of severe pancreatitis and death among patients taking exenatide, a drug approved in 2005 for the treatment of type 2 diabetes (http://www.fda.gov/medwatch/safety/2007/safety07.htm#Byetta). The FDA had previously warned physicians to carefully monitor for signs of pancreatitis in patients taking this drug.

First Page Preview View Large
First page PDF preview
First page PDF preview